伏隔核
MEF2C公司
SNi公司
神经病理性疼痛
地昔帕明
Mef2
慢性疼痛
神经科学
神经损伤
长时程增强
周围神经损伤
医学
增强子
多巴胺
心理学
生物
转录因子
内科学
坐骨神经
抗抑郁药
受体
生物化学
海马体
水解
酸水解
基因
作者
Randal A. Serafini,Zahra Farzinpour,Vishwendra Patel,Abigail M. Kelley,Molly Estill,Kerri D. Pryce,Farhana Sakloth,Collin D. Teague,Angélica Torres‐Berrío,Eric J. Nestler,Li Shen,Schahram Akbarian,Anushree N. Karkhanis,Robert D. Blitzer,Venetia Zachariou
出处
期刊:Pain
[Ovid Technologies (Wolters Kluwer)]
日期:2024-07-09
卷期号:165 (12): 2733-2748
标识
DOI:10.1097/j.pain.0000000000003316
摘要
Preclinical and clinical work has demonstrated altered plasticity and activity in the nucleus accumbens (NAc) under chronic pain states, highlighting critical therapeutic avenues for the management of chronic pain conditions. In this study, we demonstrate that myocyte enhancer factor 2C (MEF2C), a master regulator of neuronal activity and plasticity, is repressed in NAc neurons after prolonged spared nerve injury (SNI). Viral-mediated overexpression of Mef2c in NAc neurons partially ameliorated sensory hypersensitivity and emotional behaviors in mice with SNI, while also altering transcriptional pathways associated with synaptic signaling. Mef2c overexpression also reversed SNI-induced potentiation of phasic dopamine release and neuronal hyperexcitability in the NAc. Transcriptional changes induced by Mef2c overexpression were different than those observed after desipramine treatment, suggesting a mechanism of action different from antidepressants. Overall, we show that interventions in MEF2C-regulated mechanisms in the NAc are sufficient to disrupt the maintenance of chronic pain states, providing potential new treatment avenues for neuropathic pain.
科研通智能强力驱动
Strongly Powered by AbleSci AI